Disease/Infection News

RSS

No evidence of pre-existing antibody and B cell immunity against SARS-CoV-2 in unexposed adults

A group of researchers analyzed the B cell response to SARS-CoV-2 in unexposed individuals.

10 Sep 2021

Virus-like nanoparticle vaccine effective against SARS-CoV-2 in animal model

A COVID-19 vaccine, created from a virus-like nanoparticle that displays SARS-CoV-2 spike protein RBDs, effectively protects animal model from infection.

10 Sep 2021

New method facilitates the identification of young people at risk of sexual ill health

A procedure that uses written questions to identify visitors to youth clinics who have experienced or risk experiencing sexually transmitted infections, unplanned pregnancy or sexual violence is receiving high praise from personnel and visitors. This is the conclusion of a doctoral thesis from Linköping University, Sweden.

9 Sep 2021

Autoimmune antibodies strongly linked to the severity of illness in COVID-19 patients

The presence of special immune system defense molecules, called autoimmune antibodies, has been strongly tied to how poorly people fare when hospitalized with COVID-19, a new study shows.

9 Sep 2021

Novel combination therapy may prolong viral suppression in patients with HIV

A novel combination treatment may increase the ability of monoclonal antibodies to control viral infection in patients diagnosed with HIV, according to a Northwestern Medicine study published in Science Translational Medicine.

9 Sep 2021

Report highlights the health effects of COVID-19 on Australians during 2020 and early 2021

A new report into the health effects of COVID-19 on Australians during 2020 and early 2021 includes analyses of the years of healthy life lost, international comparisons and impacts on population groups, mental health and the health system.

9 Sep 2021

Are bat retroviruses a threat to humans?

Zoonotic viruses that bats transmit are capable of infecting humans and have caused devastating infections throughout the world.

9 Sep 2021

Early impact of COVID-19 vaccines in Stockholm, Sweden

A study shows that the early programmatic effects of vaccinating high-risk individuals can reduce infection and mortality by SARS-CoV-2.

9 Sep 2021

Healthy plant-based foods may lower COVID-19 risk and severity

Although metabolic conditions such as obesity and type 2 diabetes have been linked to an increased risk of COVID-19, as well as an increased risk of experiencing serious symptoms once infected, the impact of diet on these risks is unknown.

9 Sep 2021

Stimulus program increased low-income population’s spending, study reveals

The coronavirus pandemic disrupted the U.S. economy, yet the dynamics of micro-level consumer spending among low-income populations are not well understood.

9 Sep 2021

Understanding the changing coronavirus landscape

With the emergence of new SARS-CoV-2 variants such as beta and delta, people are not only getting a refresher course on the Greek alphabet but also experiencing confusion and anxiety about what the variants mean for public health.

9 Sep 2021

Research probes interaction between SARS-CoV-2 and influenza

Researchers from Germany and France tried to determine if epidemiological studies based on co-detection prevalence data can offer a reliable estimation of interactions among respiratory viruses. They designed a simulation study by building on a general epidemiological model of co-circulation of 2 respiratory viruses that cause seasonal epidemics.

8 Sep 2021

Combating the fourth wave of COVID-19 in Ontario

Researchers from Canada recently attempted to project the number of COVID-19 cases and the demand for acute hospital resources for Fall 2021 in a mid-sized southwestern Ontario community. They sought to evaluate if current vaccine coverage and contact reduction levels are sufficient to mitigate a possible 4th wave driven by the Delta variant, or if stricter public health measures need to be reinstituted.

8 Sep 2021

Mu SARS-CoV-2 variant highly resistant to neutralization by convalescent and vaccinated sera

Researchers in Japan have warned that the Mu (B.1.621) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – appears to be highly resistant to neutralization by sera from convalescent or vaccinated individuals.

8 Sep 2021

New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses

Researchers in Australia have developed a coronavirus disease 2019 (COVID-9) vaccine that induced robust and long-lived humoral and cellular immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in both young and aging mice.

8 Sep 2021

Disease/Infection News

No evidence of pre-existing antibody and B cell immunity against SARS-CoV-2 in unexposed adults

Virus-like nanoparticle vaccine effective against SARS-CoV-2 in animal model

New method facilitates the identification of young people at risk of sexual ill health

Autoimmune antibodies strongly linked to the severity of illness in COVID-19 patients

Novel combination therapy may prolong viral suppression in patients with HIV

Report highlights the health effects of COVID-19 on Australians during 2020 and early 2021

Are bat retroviruses a threat to humans?

Early impact of COVID-19 vaccines in Stockholm, Sweden

Healthy plant-based foods may lower COVID-19 risk and severity

Stimulus program increased low-income population’s spending, study reveals

Understanding the changing coronavirus landscape

Research probes interaction between SARS-CoV-2 and influenza

Combating the fourth wave of COVID-19 in Ontario

Mu SARS-CoV-2 variant highly resistant to neutralization by convalescent and vaccinated sera

New vaccinia-based COVID-19 vaccine candidate induces robust, durable immune responses

Early implementation of social distancing policies results in smaller death tolls, but larger second waves

Study: Nearly one in five patients with malignant pleural mesothelioma contracted COVID-19

Study measures the impact of stigma and discrimination on positive COVID-19 diagnosis

New suggestions emphasize the importance of contingency level care during COVID-19 pandemic

Neuropsychiatric symptoms in children and adolescents with long COVID

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News